BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35317326)

  • 21. Granulocyte transfusion in the G-CSF era.
    Price TH
    Int J Hematol; 2002 Aug; 76 Suppl 2():77-80. PubMed ID: 12430904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte-colony-stimulating factor and dexamethasone.
    Dale DC; Liles WC; Llewellyn C; Rodger E; Price TH
    Transfusion; 1998 Aug; 38(8):713-21. PubMed ID: 9709778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients.
    Adkins D; Goodgold H; Hendershott L; Johnston M; Cravens D; Spitzer G
    Bone Marrow Transplant; 1997 Apr; 19(8):809-12. PubMed ID: 9134173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.
    Hübel K; Dale DC; Engert A; Liles WC
    J Infect Dis; 2001 Jan; 183(2):321-328. PubMed ID: 11112098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers.
    Liles WC; Huang JE; Llewellyn C; SenGupta D; Price TH; Dale DC
    Transfusion; 1997 Feb; 37(2):182-7. PubMed ID: 9051093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of in vitro and in vivo cytokine treatment, leucapheresis and irradiation on the function of human neutrophils: implications for white blood cell transfusion therapy.
    Cohen DM; Bhalla SC; Anaissie EJ; Hester JP; Savary CA; Rex JH
    Clin Lab Haematol; 1997 Mar; 19(1):39-47. PubMed ID: 9146946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.
    Teipel R; Oelschlägel U; Wetzko K; Schmiedgen M; Kramer M; Rücker-Braun E; Hölig K; von Bonin M; Heidrich K; Fuchs A; Ordemann R; Kroschinsky F; Bornhäuser M; Hütter G; Schmidt H; Ehninger G; Schetelig J; Heidenreich F
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2171-2177. PubMed ID: 29935214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil migration in canines: in vivo comparison of granulocyte function following 24-hour storage at 6 or 20 degrees C of leukocyte concentrates or of granulocytes purified by counterflow centrifugation--elutriation.
    Jemionek JF; Monroy RL; Baker WH; Walden DA
    Cryobiology; 1983 Feb; 20(1):7-16. PubMed ID: 6831911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF.
    de Fabritiis P; Iori AP; Mengarelli A; Gozzer M; Ferrazza G; De Propris MS; Romano A; Arcese W
    Transfusion; 2001 Feb; 41(2):190-5. PubMed ID: 11239221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial granulocytapheresisunder daily administration of rHuG-CSF: effects on peripheral blood counts, collection efficiency, and yield.
    Worel N; Kurz M; Peters C; Höcker P
    Transfusion; 2001 Mar; 41(3):390-5. PubMed ID: 11274596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hours.
    Murea S; Fruehauf S; Zeller WJ; Haas R
    J Hematother; 1996 Aug; 5(4):351-7. PubMed ID: 8877710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in nonneutropenic surgical intensive care patients.
    Gerber A; Struy H; Weiss G; Lippert H; Ansorge S; Schulz HU
    J Interferon Cytokine Res; 2000 Dec; 20(12):1083-90. PubMed ID: 11152575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte concentrates: how can we assess their quality?
    Bashir S; Cardigan R
    Transfus Med; 2003 Oct; 13(5):245-57. PubMed ID: 14617335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lenograstim with or without dexamethasone for neutrophil mobilization in healthy donors: short-term kinetics of white blood cells and effects of granulocyte apheresis.
    Kessler K; Goudeva L; Heuft HG
    J Clin Apher; 2011 Dec; 26(6):338-46. PubMed ID: 22072548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dexamethasone promotes granulocyte mobilization by prolonging the half-life of granulocyte-colony-stimulating factor in healthy donors for granulocyte transfusions.
    Hiemstra IH; van Hamme JL; Janssen MH; van den Berg TK; Kuijpers TW
    Transfusion; 2017 Mar; 57(3):674-684. PubMed ID: 28032635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor.
    Caspar CB; Seger RA; Burger J; Gmür J
    Blood; 1993 Jun; 81(11):2866-71. PubMed ID: 7684619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
    Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
    Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
    J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic enzyme levels are increased during granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization in human donors but do not predict the number of mobilized stem cells.
    van Os R; van Schie ML; Willemze R; Fibbe WE
    J Hematother Stem Cell Res; 2002 Jun; 11(3):513-21. PubMed ID: 12183836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.